FDA update on Chinese infant formula contamination
A U.S. Food and Drug Administration (FDA) investigation of more than 1,000 retail markets which may have brought Chinese infant formula into the U.S. yielded no such items, the FDA stated.
A U.S. Food and Drug Administration (FDA) investigation of more than 1,000 retail markets which may have brought Chinese infant formula into the U.S. yielded no such items, the FDA stated.
The FDA had previously advised on September 12 that consumers should not purchase any baby formula from China, after Chinese officials reported that a tainted, milk-based formula led to the death of one baby and may have caused kidney stones in dozens of others.
Since then, the melamine-tainted formula has been linked to nearly 53,000 sickened infants, nearly 13,000 hospitalizations, and four infant deaths, according to the Associated Press.
Major congenital malformations not linked to first trimester tetracycline use
November 22nd 2024A large population-based study found that first-trimester tetracycline exposure does not elevate the risk of major congenital malformations, though specific risks for nervous system and eye anomalies warrant further research.
Higher pregnancy risks associated with maternal hidradenitis suppurativa
November 8th 2024A study of over 1 million births in Quebec reveals that pregnant women with hidradenitis suppurativa face increased risks of pregnancy complications and long-term health issues for both themselves and their offspring.
Low vitamin D levels associated with slowed fracture healing
September 29th 2024“Getting outside and enjoying the fresh air can do wonders for your health while also upping Vitamin D absorption, said Jessica McQuerry, MD, lead study author of an abstract presented at the 2024 AAP National Conference & Exhibition.
